Research: Rockefeller team finds flawed data in recent study relevant to coronavirus antiviral development
New York, July 09, 2025.- The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-Cov-2’s molecular structure known as the NiRAN domain—an enzyme region essential to viral replication that’s common to many coronaviruses.Continuar Leyendo



















